A61K 49/122
Dimers of complexes or complex-forming compounds
Official title: {dimers of complexes or complex-forming compounds}
A61K49/122 (Dimers of complexes or complex-forming compounds) appears on 35 US grants and 39 published applications in this corpus.
Search patents in A61K- Granted patents
- 35
- Published applications
- 39
- Assignees
- 26
- Inventors
- 94
- Latest grant
- 8 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 3 |
| 2003 | 1 | 4 |
| 2004 | 3 | 1 |
| 2005 | 1 | 4 |
| 2006 | 3 | 5 |
| 2007 | 2 | 3 |
| 2008 | 2 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 3 |
| 2012 | 1 | 1 |
| 2013 | 3 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Cyclodextrin-linked polyvalent ligands for complexation of metal ions8 Aug 2023US 11,717,580 B2
- Dimeric contrast agents2 Aug 2022US 11,401,262 B2Bracco Imaging S.P.A.
- Dimeric contrast agents5 Jan 2021US 10,882,849 B2Bracco Imaging S.P.A.
- Dimeric contrast agents6 Oct 2020US 10,793,533 B2Bracco Imaging S.P.A.
- Dimeric contrast agents10 Sep 2019US 10,407,412 B2Bracco Imaging S.P.A.
- Process for the manufacturing of a gadolinium complex solution12 Sep 2024US 2024/0299594 A1Bracco Imaging S.P.A.
- Cyclodextrin-linked polyvalent ligands for complexation of metal ions5 Aug 2021US 2021/0236661 A1
- Dimeric contrast agents28 Jan 2021US 2021/0024500 A1Bracco Imaging S.P.A.
- Dimeric contrast agents22 Oct 2020US 2020/0331893 A9Bracco Imaging S.P.A.
- Dimeric contrast agents16 Jan 2020US 2020/0017453 A1Bracco Imaging S.P.A.
Most cited
By later US patents
- Metal-binding targeted polypeptide constructs92US 5,449,761 ACytogen Corporation · 1995
- Metal complexes derivatized with folate for use in diagnostic and therapeutic applications84US 6,093,382 ABracco Research USA · 2000
- Porphyrazine optical and dual optical/MR contrast and therapeutic agents54US 8,540,967 B2Hoffman/Barrett, L.L.C. · 2013
- Phthalamide lanthanide complexes for use as luminescent markers48US 6,515,113 B2The Regents of the University of California · 2003
- Metal-binding targeted polypeptide constructs40US 5,593,656 ACytogen Corporation · 1997